Andreakos, E., Foxwell, B., & Feldmann, M. (2004). Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?
Chicago Style (17th ed.) CitationAndreakos, E., B. Foxwell, and M. Feldmann. Is Targeting Toll-like Receptors and Their Signaling Pathway a Useful Therapeutic Approach to Modulating Cytokine-driven Inflammation? 2004.
ציטוט MLAAndreakos, E., et al. Is Targeting Toll-like Receptors and Their Signaling Pathway a Useful Therapeutic Approach to Modulating Cytokine-driven Inflammation? 2004.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.